Immune cell trafficking to the islets during type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Autoimmune Diseases

Background:

• Immune cell infiltration into pancreatic islets drives type 1 diabetes (T1D) pathogenesis.
• Targeting immune cell trafficking is a validated strategy in other autoimmune conditions.
• Current strategies for inhibiting islet immune cell trafficking in T1D face challenges due to redundant molecular pathways.

Purpose of the Study:

• To review current knowledge on immune cell trafficking to pancreatic islets in T1D.
• To identify potential therapeutic targets for inhibiting T1D progression.

Main Methods:

• Literature review of factors mediating immune cell trafficking in T1D.
• Analysis of adhesion molecules, chemokines, and cellular interactions involved in islet infiltration.

Main Results:

• Immune cell trafficking to islets in T1D involves complex and redundant adhesion and chemokine systems.
• Cognate antigen recognition is not consistently required for T cell entry into islets.
• Myeloid cells play a crucial role in facilitating T and B cell entry into the pancreatic islets.

Conclusions:

• Myeloid cells represent a potential convergence point for therapeutic intervention in T1D.
• Understanding immune cell trafficking pathways is essential for developing effective T1D treatments.
• Targeting myeloid cell-mediated immune cell entry offers a novel therapeutic avenue for type 1 diabetes.